Atlas Trials

Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer

Clinical trial NCT06514118 · RECRUITING

Trial details

NCT number
NCT06514118
Sponsor
Qingdao Central Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Small-cell Lung CancerResidual TumorRadiation
Start date
2024-04-17
Primary completion
2026-03-16
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.